However, the majority of HGSOC patients display loss of p53 and TP53MUT tumor cells predominantly relying on S and G2/M cell cycle checkpoints strictly regulated by the ATR/CHK1 pathway. The gene discussed is CHEK1; the disease is neoplasm.